From SourceWatch
Jump to navigation Jump to search

Ventracor Limited (VCR) "is primarily involved in the development of the 'VentrAssist' ventricular assist device for the management of end-stage congestive heart failure. VCR gained European approval in Dec-06, allowing the commencement of commercial sales in Europe in early CY07. The same device is still currently navigating its way through a US feasibility study as VCR works towards gaining FDA approval for VentrAssist." [1]


Accessed November 2008: [2]

Resources and articles

Related Sourcewatch articles


  1. Ventracor, InvestSmart, accessed November 25, 2008.
  2. Directors, InvestSmart, accessed November 25, 2008.